Full-Time

Technical Service Lead

Robotic Capital Systems

Posted on 1/26/2026

Mendaera

Mendaera

51-200 employees

Delivers point-of-care medical devices

Compensation Overview

$130k - $141.5k/yr

Tampa, FL, USA

Hybrid

Central/Eastern U.S. preferred; West Coast must work EST hours; periodic on-site visits required.

Category
Electrical Engineering (1)
Required Skills
Linux/Unix
Requirements
  • Bachelor’s degree in Engineering, Biomedical Engineering, or related field.
  • Experience with robotics, imaging, or advanced capital equipment.
  • 5+ years supporting capital medical devices or complex electromechanical systems.
  • Hands-on experience troubleshooting embedded Linux systems on physical products (not enterprise IT).
  • Experience supporting customers in clinical or field environments.
  • Strong understanding of FDA-regulated product support (FDA, ISO 13485).
  • Ability to clearly communicate technical issues to clinical, sales, and non-technical teams.
  • Willingness to travel for customer and commercial support.
Responsibilities
  • Serve as the primary escalation point for complex issues involving robotic capital systems, integrated software, and peripherals across installation, clinical use, and early commercial deployments.
  • Provide advanced remote support and periodic on-site field support for installations, early adoption, and complex escalations.
  • Troubleshoot electromechanical and system-level issues, including diagnostics and log analysis in embedded Linux device environments using approved service procedures.
  • Partner closely with Sales, Clinical, Service, Engineering, and Quality to resolve customer issues safely and efficiently.
  • Develop and maintain a service knowledge base (troubleshooting guides, known issues, and escalation guidance) and contribute to service readiness for hardware and software releases.
  • Support post-market activities, including complaints, CAPA input, and field feedback to engineering.
Desired Qualifications
  • Experience building or contributing to service knowledge bases.
  • Experience supporting software or firmware updates on deployed medical devices.
  • Clinical exposure in hospital or ASC environments.

Mendaera provides medical devices and healthcare technology designed to support clinicians at the point of care. Its solutions help doctors and nurses perform procedures with higher precision and consistency directly where patients receive treatment, aiming to streamline care and improve outcomes. The devices integrate into the care workflow to reduce unnecessary patient movement, speed recovery, and lower overall costs. Revenue comes from selling these technologies to hospitals, clinics, and individual practitioners, with engagement also involving administrators and payors to align value and reimbursement. The company adheres to regulatory standards to ensure safety and effectiveness, partnering with regulators and stakeholders to bring compliant technologies to market. Overall, Mendaera’s goal is to improve patient outcomes, boost patient satisfaction, and reduce the cost of care by making medical interventions more efficient at the point of care.

Company Size

51-200

Company Stage

Series B

Total Funding

$97M

Headquarters

San Carlos, California

Founded

2020

Simplify Jobs

Simplify's Take

What believers are saying

  • First procedures completed September 2025; full commercialization launch planned for 2026.
  • Expanding from urology to multiple specialties addresses hundreds of millions of annual procedures.
  • Healthcare provider workforce shortages create urgent demand for precision automation at point-of-care.

What critics are saying

  • Intuitive Surgical dominates surgical robotics; could extend into handheld interventions and block Mendaera.
  • Reimbursement payers may classify Focalist as incremental improvement, capping pricing power.
  • Limited early adoption or complications in urology cases delay 2026 commercialization and market confidence.

What makes Mendaera unique

  • Focalist combines handheld robotics with real-time ultrasound imaging for precise needle placement.
  • FDA-cleared system addresses clinical skill variability requiring years of training to master.
  • Partnerships with Cook Medical and EchoNous integrate market-leading needles and portable ultrasound.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Mendaera who can refer or advise you

Benefits

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

3%

1 year growth

0%

2 year growth

5%
Archyde
Jul 8th, 2025
Mendaera Secures $73M to Revolutionize Robotics

Mendaera, a healthcare robotics firm, secured $73 million in Series B funding, following a $24 million Series A led by Lux Capital in 2023. The funds will help scale their robotic and AI technologies for medical procedures like biopsies and organ access. Mendaera is expanding partnerships, including with Cook Medical and EchoNous, to enhance needle-based interventions. They also acquired Avail Medsystems' telepresence tech to improve patient access and care delivery.

Bioscience Association Manitoba
Apr 28th, 2025
Cook Medical collaborates with Mendaera(TM) to advance needle-based intervention with handheld robotics

Cook Medical collaborates with Mendaera(TM) to advance needle-based intervention with handheld robotics.

BioSpace
Jan 9th, 2025
Mendaera Appoints Medical Robotics Leader Eric Davidson as Chief Commercial Officer

Mendaera appoints medical robotics leader Eric Davidson as Chief Commercial Officer.

Yunpaisheji
Nov 13th, 2024
Mendaera raises $73M for robotics system

Mendaera has secured $73M in venture capital to advance its handheld robotics platform for needle-based procedures like biopsy and vascular access. The Silicon Valley startup aims to address healthcare provider shortages and rising demand by integrating real-time imaging with robotic guidance. The Series B funding was led by Threshold Ventures, with participation from Lux Capital and others, to enhance patient care and expand access to high-quality medical procedures.

AuntMinnie
Oct 8th, 2024
EchoNous partners with Mendaera

Portable ultrasound company EchoNous and AI and robotics company Mendaera have established a commercial partnership to develop new ultrasound-guided technology for interventional procedures.

INACTIVE